Neopterin and macrophage inflammatory protein-1α in the cerebrospinal fluid of schizophrenic patients: No evidence of intrathecal inflammation

Neuropsychobiology

Volumn 46, Issue 4, 2002, Pages 169-172

  Nikkilä, Heikki V ^a   Ahokas, Antti ^b   Wahlbeck, Kristian ^a   Rimón, Ranan ^c   Andersson, Leif C ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

Cerebrospinal fluid; Immunity; Inflammation; Macrophage inflammatory protein 1 ; Neopterin; Schizophrenia

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEOPTERIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PSYCHOSIS; RADIOIMMUNOASSAY; SCHIZOPHRENIA;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; NEOPTERIN; RADIOIMMUNOASSAY; SCHIZOPHRENIA;

EID: 12244275241     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067805     Document Type: Article

References (39)

1. Achiron A, Noy S, Pras E, Lereya J, Hermesh H, Laor N: T-cell subsets in acute psychotic schizophrenic patients. Biol Psychiatry 1994;35:27-31.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Press, 1994.
3. Arnold SE: Neurodevelopmental abnormalities in schizophrenia: Insights from neuropathology. Dev Psychopathol 1999;11:439-456.
4. Arnold SE, Ruscheinsky DD, Han LY: Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol Psychiatry 1997;42:639-647.
5. Cazzullo CL, Saresella M, Roda K, Calvo MG, Bertrando P, Doria S, et al: Increased levels of CD8+ and CD4+ 45RA+ lymphocytes in schizophrenic patients. Schizophr Res 1998;31:49-55.
6. Dunbar PR, Hill J, Neale TJ, Mellsop GW: Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychol Med 1992;22:1051-1057.
7. Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, et al: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990;322:166-172.
8. Fricchione L, Bilfinger T, Stefano GB: The macrophage and neuropsychiatric disorders. Neuropsychiatr Neuropsychol Behav Neurol 1996;1:16-29.
9. Fuchs D, Weiss G, Wachter H: Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol 1993;101:1-6.
10. Furukawa Y, Nishi K, Kondo T, Tanabe K, Mizuno Y: Significance of CSF total neopterin and biopterin in inflammatory neurological diseases. J Neurol Sci 1992;111:65-72.
11. Gaines H, von Sydow MA, von Stedingk LV, Biberfeld G, Bottiger B, Hansson LO, et al: Immunological changes in primary HIV-1 infection. AIDS 1990;4:995-999.
12. Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D: Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis 1993;168:1285-1288.
13. Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH: A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain 1993;116:1425-1450.
14. Hirata-Hibi M, Hayashi K: The anatomy of the P lymphocyte. Schizophr Res 1993;8:257-262.
15. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, et al: Immune response-associated production of neopterin: Release from macrophages under control of interferon gamma. J Exp Med 1984;160:310-316.
16. Kokai M, Morita Y, Fukuda H, Hatotani N: Immunophenotypic studies on atypical lymphocytes in psychiatric patients. Psychiatry Res 1998;77:105-112.
17. Korte S, Arolt V, Peters M, Weitzsch C, Rothermundt M, Kirchner H: Increased serum neopterin levels in acutely ill and recovered schizophrenic patients. Schizophr Res 1998;32:63-67.
18. Lin A, Kenis G, Bignotti S, Tura GJ, De Jong R, Bosmans E, et al: The inflammatory response system in treatment-resistant schizophrenia: Increased serum interleukin-6. Schizophr Res 1998;32:9-15.
19. Millner MM, Franthal W, Thalhammer GH, Berghold A, Aigner RM, Fuger GF, et al: Neopterin concentrations in cerebrospinal fluid and serum as an aid in differentiating central nervous system and peripheral infections in children. Clin Chem 1998;44:161-167.
20. Miyagishi R, Kikuchi S, Fukazawa T, Tashiro K: Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J Neurol Sci 1995;129:223-227.
21. Muller N, Ackenheil M: Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 1998;22:1-33.
22. Naudin J, Capo C, Giusano B, Mege JL, Azorin JM: A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia? Schizophr Res 1997;26:227-233.
23. Nikkilä HV, Muller K, Ahokas A, Miettinen K, Rimón R, Andersson LC: Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes. Am J Psychiatry 1999;156:1725-1729.
24. Overall JE, Gorham DR: The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
25. Prieschl EE, Kulmburg PA, Baumruker T: The nomenclature of chemokines. Int Arch Allergy Immunol 1995;107:475-483.
26. Printz DJ, Strauss DH, Goetz R, Sadiq S, Malaspina D, Krolewski J, et al: Elevation of CD5+ B lymphocytes in schizophrenia. Biol Psychiatry 1999;46:110-118.
27. Schall TJ, Bacon KB: Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994;6:865-873.
28. Schattner A, Cori Y, Hahn T, Sirota P: No evidence for autoimmunity in schizophrenia. J Autoimmun 1996;9:661-666.
29. Spanaus KS, Nadal D, Pfister HW, Seebach J, Widmer U, Frei K, et al: C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J Immunol 1997;158:1956-1964.
30. Sperner-Unterweger B, Barnas C, Fleischhacker WW, Fuchs D, Meise U, Reibnegger G, et al: Is schizophrenia linked to alteration in cellular immunity? Schizophr Res 1989;2:417-421.
31. Sperner-Unterweger B, Barnas C, Fuchs D, Kemmler G, Wachter H, Hinterhuber H, et al: Neopterin production in acute schizophrenic patients: An indicator of alterations of cell-mediated immunity. Psychiatry Res 1992;42:121-128.
32. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Patient Version (SCID-P 4/1/88). New York Biometrics Research Department, 1988.
33. Stoll G, Jander S: The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 1999;58:233-247.
34. Wolpe SD, Cerami A: Macrophage inflammatory proteins 1 and 2: Members of a novel superfamily of cytokines. FASEB J 1989;3:2565-2573.
35. Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT, et al: Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 1988;167:570-581.
36. Woods BT: Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 1998;155:1661-1670.
37. Yolken RH, Torrey EF: Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995;8:131-145.
38. Zangerle R, Schonitzer D, Fuchs D, Most J, Dierich MP, Wachter H: Reducing HIV transmission by seronegative blood. Lancet 1992;339:130-131.
39. Zielasek J, Hartung HP: Molecular mechanisms of microglial activation. Adv Neuroimmunol 1996;6:191-222.